{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:18:45Z","timestamp":1775225925429,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["2016YFD0500400"],"award-info":[{"award-number":["2016YFD0500400"]}]},{"name":"The National Key Research and Development Program of China","award":["2016YFC1200901"],"award-info":[{"award-number":["2016YFC1200901"]}]},{"name":"National Key Technology R&D Program","award":["2013BAD12B05"],"award-info":[{"award-number":["2013BAD12B05"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.antiviral.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T21:31:59Z","timestamp":1502919119000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-8365","authenticated-orcid":false,"given":"Lei","family":"Shuai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.08.011_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3201\/eid1103.040981","article-title":"Ebola virus antibody prevalence in dogs and human risk","volume":"11","author":"Allela","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"2\u20133","key":"10.1016\/j.antiviral.2017.08.011_bib2","first-page":"135","article-title":"Assessing the potential role of pigs in the epidemiology of Ebola virus in Uganda","volume":"8","author":"Atherstone","year":"2015","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.antiviral.2017.08.011_bib3","first-page":"461","article-title":"Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs","volume":"131","author":"Bankovskiy","year":"2008","journal-title":"Dev. Biol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib4","doi-asserted-by":"crossref","first-page":"e1003389","DOI":"10.1371\/journal.ppat.1003389","article-title":"Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine","volume":"9","author":"Blaney","year":"2013","journal-title":"Plos Pathog."},{"key":"10.1016\/j.antiviral.2017.08.011_bib5","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.08.011_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.antiviral.2017.08.011_bib8","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.vaccine.2006.12.054","article-title":"The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs","volume":"25","author":"Cliquet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.08.011_bib9","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"key":"10.1016\/j.antiviral.2017.08.011_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ebiom.2017.03.045","article-title":"Dose-dependent t-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization","volume":"19","author":"Dahlke","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2017.08.011_bib11","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","article-title":"Ectodomain shedding of the glycoprotein GP of Ebola virus","volume":"23","author":"Dolnik","year":"2004","journal-title":"Embo J."},{"key":"10.1016\/j.antiviral.2017.08.011_bib12","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A\u00a0single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cbic.200600223","article-title":"Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus","volume":"7","author":"Falzarano","year":"2006","journal-title":"Chembiochem"},{"key":"10.1016\/j.antiviral.2017.08.011_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2009.10.051","article-title":"Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge","volume":"28","author":"Faul","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.08.011_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JVI.01514-06","article-title":"Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses","volume":"81","author":"Ge","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib16","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses","volume":"26","author":"Geisbert","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2017.08.011_bib17","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.08.011_bib18","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1128\/JVI.75.19.9121-9128.2001","article-title":"Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice","volume":"75","author":"Ito","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8603-8-15","article-title":"\u201cA time of fear\u201d: local, national, and international responses to a large Ebola outbreak in Uganda","volume":"8","author":"Kinsman","year":"2012","journal-title":"Glob. Health"},{"key":"10.1016\/j.antiviral.2017.08.011_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.virol.2012.06.001","article-title":"Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs","volume":"432","author":"Kong","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.08.011_bib21","first-page":"138","article-title":"Preparation of hyperimmune horse serum against Ebola virus","volume":"40","author":"Krasnianskii","year":"1995","journal-title":"Vopr. Virusol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2017.08.011_bib22","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/514294","article-title":"Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections","volume":"179","author":"Kudoyarova-Zubavichene","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.08.011_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/JVI.02308-14","article-title":"Rhabdovirus-based vaccine platforms against henipaviruses","volume":"89","author":"Kurup","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","article-title":"Multiple Ebola virus transmission events and rapid decline of central African wildlife","volume":"303","author":"Leroy","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.08.011_bib25","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","article-title":"Comprehensive analysis of Ebola virus GP1 in viral entry","volume":"79","author":"Manicassamy","year":"2005","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2017.08.011_bib26","doi-asserted-by":"crossref","first-page":"S1066","DOI":"10.1093\/infdis\/jir348","article-title":"Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy","volume":"204","author":"Marzi","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.08.011_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/13550280009018301","article-title":"Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach","volume":"6","author":"Morimoto","year":"2000","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002304","article-title":"Discovery of an Ebolavirus-like filovirus in Europe","volume":"7","author":"Negredo","year":"2011","journal-title":"Plos Pathog."},{"key":"10.1016\/j.antiviral.2017.08.011_bib29","article-title":"Dead or alive: animal sampling during Ebola hemorrhagic fever outbreaks in humans","volume":"5","author":"Olson","year":"2012","journal-title":"Emerg. Health Threats J."},{"key":"10.1016\/j.antiviral.2017.08.011_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7589\/0090-3558-45.2.363","article-title":"Aerial distribution of ONRAB\u00ae baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada","volume":"45","author":"Rosatte","year":"2009","journal-title":"J.\u00a0Wildl. Dis."},{"key":"10.1016\/j.antiviral.2017.08.011_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2015.06.011","article-title":"Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination","volume":"121","author":"Shuai","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.08.011_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.08.011_bib33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0966-842X(01)02201-6","article-title":"The pathogenesis of Ebola hemorrhagic fever","volume":"9","author":"Takada","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/1743-422X-8-454","article-title":"Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production","volume":"8","author":"Tao","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2017.08.011_bib35","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1128\/JVI.00787-10","article-title":"Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation","volume":"84","author":"Tao","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib36","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1016\/j.vaccine.2012.06.001","article-title":"Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper","volume":"30","author":"Wang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.08.011_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1196\/annals.1373.029","article-title":"Efficacy of DNA immunization with F and G protein genes of Nipah virus","volume":"1081","author":"Wang","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2017.08.011_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/srep00811","article-title":"Transmission of Ebola virus from pigs to non-human primates","volume":"2","author":"Weingartl","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2017.08.011_bib39","first-page":"211","article-title":"Review of Ebola virus infections in domestic animals","volume":"135","author":"Weingartl","year":"2013","journal-title":"Dev. Biol."},{"key":"10.1016\/j.antiviral.2017.08.011_bib40","series-title":"WHO Expert Consultation on Rabies","first-page":"1","author":"WHO","year":"2013"},{"key":"10.1016\/j.antiviral.2017.08.011_bib41","series-title":"Ebola Situation Report","author":"WHO","year":"2015"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217302097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217302097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T14:52:19Z","timestamp":1575384739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217302097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":41,"alternative-id":["S0166354217302097"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.08.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}